Glucagon Receptor Protein-VLP (GCGR)
-
- Target Alle Glucagon Receptor (GCGR) Proteine anzeigen
- Glucagon Receptor (GCGR)
- Protein-Typ
- VLP
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Verwendungszweck
- Human GCGR / Glucagon receptor Full Length Protein (VLP)
- Sequenz
- Ala 26 - Asn 432
- Produktmerkmale
- Human GCGR Full Length Protein (VLP) is expressed from human 293 cells (HEK293). It contains AA Ala 26 - Asn 432 (Accession # P47871-1).
- Endotoxin-Niveau
- 1.0 EU per μg
- Top Product
- Discover our top product GCGR Protein
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, Arginine, pH 7.4
- Lagerung
- -80 °C
- Informationen zur Lagerung
- -70°C
-
- Target
- Glucagon Receptor (GCGR)
- Andere Bezeichnung
- GCGR (GCGR Produkte)
- Hintergrund
- The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of type 2 diabetes mellitus (T2DM) . The ever increasing prevalence of type 2 diabetes mellitus in the developed and developing nations calls for the introduction of new and more effective treatments. Glucagon receptor (GCGR) antagonists are highly validated in preclinical models of T2DM and thus have the potential to be developed as a new therapy.
- Pathways
- Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
-